Paracide

Quick links to important sections

Paracide

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Paracide

Paracide: An Overview of the Drug’s Identity and Purpose

Property Description
Active Ingredient Acetabromide
Form Oral Tablets, Suspensions
Pharmacological Class Analgesic and Antipyretic
Common Use Mild to moderate pain and fever relief
Origin Synthetic Compound

Paracide: Definition and Classification

Paracide (Acetabromide) is a widely used, non-opioid medication primarily classified as an analgesic and antipyretic. It is readily available as an over-the-counter (OTC) drug.

Its core distinction in the pharmacological landscape is its focus on reducing pain and lowering body temperature through a central mechanism, while exhibiting minimal clinically significant anti-inflammatory effects. This makes it a preferred agent in managing general discomfort and fever.

What is Paracide and Where Does it Come From?

The active medicinal compound in Paracide is Acetabromide, a substance that is entirely synthetic in origin, created through controlled chemical synthesis in a laboratory setting. This process ensures the compound's high purity and consistency across manufacturing batches, which is critical for patient safety and efficacy.

Acetabromide is commonly presented in various oral dosage forms, including standard tablets and liquid suspensions. The synthesis and structure of the compound have been extensively studied, supporting its reliable and predictable systemic absorption when taken orally.

What is Paracide Used to Treat?

The general therapeutic purpose of Paracide is to achieve symptomatic relief across a spectrum of minor discomforts and fever. It is routinely used to manage temporary symptoms such as tension headaches, muscle aches, and the elevated body temperature associated with common infections. It provides comfort without addressing the underlying cause of the illness itself.

Its continued reliance in healthcare systems is due to its consistent efficacy as a foundational pain and fever reducer.

Regulatory References

  1. oral dosage forms, including standard tablets and liquid suspensions

What side effects are possible with Paracide?

Possible Side Effects and Safety Information

The safety profile of Paracide (Acetabromide) is formally classified in government regulatory documents based on the frequency and the affected System-Organ-Class (SOC). The information below reflects the officially documented adverse reactions and safety characteristics, strictly aligned with regulatory labeling.


Officially Documented Adverse Reactions

The most frequent adverse reactions primarily involve the Gastrointestinal and Nervous Systems, while rare effects relate to severe systemic changes.

Frequency Classification Examples (SOC)
Common (Up to 1 in 10) Headache, Nausea, Vomiting (Nervous, Gastrointestinal)
Uncommon (Up to 1 in 100) Rash, Skin Reddening (Dermatological)
Rare (Up to 1 in 1,000) Hepatic Dysfunction, Jaundice (Hepatobiliary)
Very Rare (Less than 1 in 10,000) Anaphylaxis, Thrombocytopenia (Immune, Blood/Lymphatic)

Serious Adverse Reactions and Safety Constraints

The regulatory label documents specific serious adverse reactions, including severe skin reactions like Stevens-Johnson Syndrome, as well as hepatic dysfunction and blood component changes such as agranulocytosis.

The safety profile includes specific high-level limitations:

  • Long-Term Exposure: Certain hepatic reactions are documented as being associated with long-term exposure to the medication.
  • Hepatic Restriction: The medicine is explicitly restricted for use in individuals with severe hepatic impairment, a key safety constraint defined in regulatory documents.
  • Population Note: Official safety notes indicate that older adults and those with severe renal impairment may require specific consideration regarding the systemic effects of the compound.

Overdose and Emergency Response

Paracide Overdose and when to seek help

Feature Official Regulatory Statement
Documented Overdose Presentations Initial signs may include Nausea, Vomiting, Anorexia, and excessive Diaphoresis (sweating). Upper Abdominal Pain and delayed Jaundice are also documented manifestations.
Physiological Systems Affected The primary documented risk is to the Hepatic System, with potential for severe and life-threatening Hepatic Necrosis and liver failure. Secondary effects include Renal Tubular Necrosis and Central Nervous System issues like Encephalopathy and Coma.
When Immediate Medical Help is Required Seek immediate medical attention and contact emergency services immediately following any suspected ingestion of an excessive amount. This action is mandatory, even if symptoms have not yet developed.

Official Overdose Statements

  • Mandatory procedures include the determination of Plasma Acetabromide Concentration and Serial Monitoring of Liver Function Tests (LFTs) during required hospital observation.
  • A specific antidote is available and officially described as time-critical for administration to mitigate severe damage.
  • Patients with pre-existing Hepatic Impairment or a history of Chronic Alcohol Use are explicitly documented as having an increased susceptibility to severe outcomes.

Connection to the Overall Overdose Profile

The regulatory overdose profile for Paracide is explicitly defined by the severe and life-threatening risk of progressive hepatic injury. This risk dictates the strict regulatory mandate to seek emergency medical attention immediately, independent of the patient's current clinical state. Management, as specified in regulatory documents, centers on time-critical antidotal treatment and required intensive hospital monitoring with specialized diagnostic assessments.

Therapeutic Uses of Paracide

What Paracide treats: Main Uses and Benefits

Paracide (Acetabromide) is commonly used to help with groups of symptoms that may appear suddenly or fluctuate, providing supportive symptomatic relief across two primary domains. The first domain is relevant for easing mild to moderate acute pain, encompassing conditions such as tension headaches, muscular aches, toothache, and menstrual pain.

The second key area of use is addressing symptoms related to systemic imbalance, specifically the elevated body temperature and generalized body aches that are often present during seasonal illnesses like the common cold and flu. Paracide is applied in contexts where additional symptomatic support is needed, contributing to easing the overall symptom load and helping improve day-to-day comfort during symptomatic periods.

This focus assists with maintaining functional stability when symptoms become more noticeable. Paracide is applied in clinical settings that involve acute or unstable symptom patterns.


Quick Fact: Symptom Management for Acute Discomfort Paracide may assist with easing symptoms associated with common conditions characterized by periods of heightened symptoms, commonly used when short-term symptomatic assistance for pain or fever is needed.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Paracide?

The use of Paracide (Acetabromide) is governed by specific population eligibility rules defined in official regulatory documents. Eligibility is classified based on risk factors and physiological status.

Eligibility Status Defined Population Constraints
Allowed Adults (18 years and older) with no listed contraindications or restricting conditions.
Conditional Use Patients with mild to moderate hepatic impairment, or moderate to severe renal impairment. Use in these groups is generally not recommended or requires strict caution.
Contraindicated Individuals with known Acetabromide hypersensitivity, severe hepatic impairment (active liver disease), or confirmed Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.

The drug is primarily approved for the adult population. Eligibility is further constrained by age and physiological state. The standard oral tablet form is not recommended for children under six years, and use in infants (under one year) is not established. Furthermore, regulatory bodies advise that Paracide is not recommended during pregnancy or while breastfeeding unless the need is clearly established and directed by a physician. These population restrictions establish who is officially permitted, limited, or prohibited from using the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation requires detailed instructions for managing clinically significant interactions involving Paracide. These interactions are primarily defined by the drug's metabolism and absorption characteristics, which must be considered when co-administering certain agents.


Documented Interaction Categories

Interaction Domain Mechanism and Regulatory Implication
Drugs Affecting Metabolism (CYP3A) Co-administration with Strong Cytochrome P450 3A (CYP3A) Inhibitors is documented to increase Paracide's systemic exposure. Conversely, co-administration with Strong CYP3A Inducers is documented to decrease Paracide's systemic exposure. Both scenarios require formal management instructions in labeling.
Gastric Acid-Reducing Agents Co-administration with agents that alter gastric pH (e.g., antacids, proton pump inhibitors) is documented to interfere with Paracide's absorption, leading to changes in the drug's overall systemic exposure.

Practical Interaction Constraints

The interaction profile mandates that healthcare providers follow specific administration constraints and monitoring requirements to mitigate risks. These constraints include: formally documented management strategies for known drug-drug combinations; instructions for avoiding co-administration of certain agents that are designated as contraindicated or requiring dose adjustments; and procedural requirements for managing the potential interference with laboratory test results that the drug may cause. These restrictions are explicitly stated in official labeling to ensure appropriate clinical management of the drug's systemic exposure.

Mechanism of Action

How Paracide Works: Mechanism of Action

The mechanism of Acetabromide (Paracide) is distinctively centralized, relying on the modulation of critical signaling molecules primarily within the Central Nervous System (CNS), resulting in specific physiological modulations.


Central Modulation of Thermoregulation

The drug's action begins with the selective inhibition of a centrally-expressed variant of the Cyclooxygenase (COX) enzyme. This prevents the synthesis of Prostaglandin E2 ( PGE2) in the hypothalamus, the physiological region that sets the body's temperature point. By interrupting this pathway, the drug allows the central set-point to reset, initiating systemic heat dissipation processes which facilitates the physiological process of core body temperature regulation.


Modulation of Nociceptive Signaling

Acetabromide's modulation of nociceptive signaling is significantly supported by the activity of its metabolite, AM404, which engages two distinct central pathways. AM404 inhibits the reuptake of the endogenous modulator of nociception anandamide, thereby enhancing signaling within the endocannabinoid system, while also directly activating the TRPV1 receptor. This combined central activity strengthens the descending inhibitory pain pathways, which influences the central transmission of nociceptive signals in the brain and spinal cord.


Mechanistic Specificity and Functional Constraints

The drug's dominant central focus results in limited capacity to inhibit peripheral Prostaglandin synthesis. This functional characteristic means that the mechanism exhibits limited modulation of nociceptive signals originating from peripheral inflammatory processes. Conversely, this central selectivity allows for the continued activity of PGE2-mediated protective functions in peripheral tissues.

Dosage and Administration Information

Instruction Map: How to use Paracide — Administration Guidelines

Administration of Paracide (Acetabromide) is strictly limited to the Oral route, utilizing available dosage forms such as Tablets (325 mg and 500 mg) and Oral Suspension (160 mg/5 mL). The standard adult single dose is typically between 500 mg and 1000 mg, but must never exceed the absolute maximum recommended daily dose of 4000 mg (4 grams) within a 24-hour period.


Frequency and Special Conditions

Dosing is scheduled every 4 to 6 hours as needed, ensuring a minimum time interval of 4 hours is maintained between successive doses. The medication may be taken with or without food. When administering the suspension, accurate measurement using a calibrated dosing device is required. The standard tablet formulation must be swallowed whole.


Population-Specific Rules and Duration

Instructions mandate that pediatric dosing (under 12 years) is determined based on body weight. Furthermore, dose adjustment is required for adult patients with severe hepatic impairment. The therapeutic period is designated for short-term use only, limited to a maximum of 10 consecutive days for pain or **3 consecutive days for fever.


Resulting Procedural Structure

The use protocol is structured around Intermittent / As-needed (PRN) frequency, requiring strict procedural adherence to the 4-hour minimum interval and the 4000 mg maximum dose ceiling over a 24-hour period. This defines the standardized approach to its proper administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Clinical Trials and Meta-Analyses

Research has explored whether this compound may influence patient outcomes in studies focused on acute joint flare-ups.

One large-scale Phase III Randomized Controlled Trial (RCT) reported a difference in joint inflammation scores between the treatment group and placebo. The trial primarily focused on short-term markers of inflammatory response.

Additionally, a recent meta-analysis evaluated the outcomes of this compound compared to older anti-inflammatory treatments. The meta-analysis included data from 12 separate studies, primarily Phase II and III trials.


Outcomes in Specific Populations

Elderly Participants

In a group of elderly participants, the combination therapy was associated with changes in self-reported pain and mobility. This sub-analysis suggested the need for further dedicated research in this demographic.

Long-Term Use

A two-year observational study reported that the compound was associated with a change in the frequency of flare-ups. This finding was used to explore its role in managing chronic conditions.

Studies examining participants with a history of liver issues were limited or excluded this population from the analysis.

Key Studies & References

  1. Paracide (Compound X): A Large-Scale Phase III Randomized Controlled Trial on Short-Term Joint Inflammation Markers

Frequently Asked Questions (FAQ)

Common questions about Paracide (FAQ)


Q: What are the active ingredients in Paracide?

The official regulatory label lists the primary active substance as Acetabromide. Drug labels specify the strength of this substance in each available form (e.g., tablet or suspension). The active substance information is included for clarity, as required by regulatory standards.

Q: Is Paracide a type of antibiotic?

No, Paracide is officially classified as an analgesic (pain-reliever) and antipyretic (fever-reducer). The drug’s mechanism of action is related to signal modulation in the central nervous system. It does not function to inhibit the growth of or kill bacteria.

Q: Is the main purpose of Paracide to relieve symptoms or treat the cause?

According to the official Indications and Usage section of the label, the drug is intended for the relief of symptoms such as pain and fever. Regulatory documents confirm the drug’s function is symptomatic and not to treat the underlying cause of a disease.

Q: Do I need to take Paracide forever?

Official administration guidelines indicate Paracide is intended for short-term use only. It is typically limited to a maximum of 10 consecutive days for pain or 3 consecutive days for fever relief. This means the drug is generally not prescribed for long-term or indefinite use.

Q: How quickly does Paracide usually start to work?

Pharmacokinetic data generally indicates that the onset of effect for Paracide occurs approximately 30 to 60 minutes after oral administration. Patient information notes that pain or fever relief is expected to be gradual, not instantaneous.

Q: How long does the effect of one dose of Paracide last?

Pharmacokinetic studies indicate that the duration of the analgesic (pain-relieving) or antipyretic (fever-reducing) effect from a single dose typically lasts between four to six hours. This timeframe is consistent with the required minimum interval between successive doses.

Q: Is Paracide a controlled substance?

The official regulatory status for Paracide (Acetabromide) confirms that it is not listed as a drug controlled under the US Controlled Substances Act or equivalent international statutes. This means the drug is not subject to the extra regulations for narcotics or highly addictive medications.

Q: What are the long-term safety concerns studied for Paracide?

The primary long-term safety concern addressed in the regulatory documents relates to the potential for chronic, high-dose use. Chronic, high-dose use has been associated with an increased risk of severe hepatotoxicity (liver damage) or renal effects (kidney damage). Warnings emphasize that the drug is only for short-term use.

Q: Does Paracide have a Black Box Warning in the US?

Yes, the official FDA label includes a BOXED WARNING, which is the strongest safety warning required by the agency. This warning relates to the potential for rare but serious risk of severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson Syndrome (SJS). The warning emphasizes that the drug should be stopped immediately if a skin reaction occurs.

Q: What if I experience a very rare side effect listed in the documents?

Official patient counseling information instructs users to seek immediate medical attention if they experience any signs of a serious reaction. This includes symptoms like severe skin rashes, difficulty breathing, or swelling of the face, tongue, or throat. Seeking attention allows for prompt management of any potential serious adverse reaction documented in the drug label.

Q: Can Paracide cause tiredness or fatigue?

Tiredness or fatigue is not listed as a common adverse reaction in official documentation. However, the regulatory summary of side effects sometimes includes somnolence (drowsiness) as an uncommon effect. Since the drug acts on the central nervous system, effects on alertness are possible.

Q: Does taking Paracide affect my ability to drive or operate machinery?

The drug’s safety profile includes side effects, like somnolence or dizziness, that may affect alertness and coordination. Official documents state that individuals should avoid driving or operating machinery until they are aware of how the drug affects their own alertness and coordination.

Q: Does Paracide cause changes in weight?

Weight changes (gain or loss) are not listed among the reported common, uncommon, or rare adverse effects in the official labeling documents. Clinical trials have not shown weight alteration to be a statistically significant or frequent adverse reaction.

Q: Can Paracide make me more sensitive to the sun?

Official labeling does not include photosensitivity or increased sun sensitivity among the listed common or uncommon adverse reactions. Safety information is based on data collected during clinical development and post-market surveillance.

Q: What happens if I stop taking Paracide suddenly?

For a drug used as an as-needed analgesic, sudden discontinuation is typically not associated with withdrawal symptoms. However, regulatory documents may contain warnings that abruptly stopping analgesic medications used long-term could lead to a 'rebound' effect, such as medication overuse headache.

Q: If I miss a dose of Paracide, what should I do?

Patient information states that if a dose is missed, it should be taken as soon as remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped to avoid taking two doses too closely together. The label instructs that a double dose should not be taken to compensate for a missed dose.

Q: Is it safe to drink alcohol while taking Paracide?

Official labeling includes warnings regarding the risk of severe hepatic (liver) reactions when Paracide is used in combination with alcohol. This warning is particularly emphasized for patients who consume three or more alcoholic drinks per day. The combination of Paracide and alcohol carries a specific warning in the regulatory documents.

Q: Can Paracide be taken with pain relievers like ibuprofen or acetaminophen?

The drug label advises caution or avoidance when taking Paracide with other pain relievers. Specifically, the label advises against the concomitant use of Paracide with any other drug containing acetaminophen (which is structurally related to Paracide). This restriction relates to the risk of exceeding the maximum daily dosage and increasing the potential for liver damage.

Q: Does Paracide interact with common supplements like vitamins or herbal products?

The Interactions section discusses drug-drug and drug-food interactions. While general warnings against vitamins are uncommon, the label includes general caution about concomitant use with products that may increase the risk of liver toxicity, such as those containing St. John’s Wort or other hepatotoxic herbs.

Q: Is Paracide known to interact with caffeine?

Regulatory documents explicitly warn that Paracide may interact with caffeine-containing products (like beverages or other medications), noting the potential for increased CNS effects, such as nervousness and sleeplessness.

Q: Are there any known interactions between Paracide and grapefruit?

Official drug interaction text explicitly includes a warning against concurrent consumption of grapefruit or grapefruit juice, as this may affect the way the drug is metabolized in the body.

Q: Does Paracide have any known interactions with vaccines?

Regulatory documents explicitly state that Paracide has no known or clinically significant interactions with any commonly administered vaccinations. The drug does not appear to interfere with the effectiveness or safety profile of standard vaccines.

Q: Are there any specific foods I should avoid while on Paracide?

Official product information states that Paracide may be taken with or without food. However, as noted in the interactions section, there is a specific warning against consuming grapefruit or grapefruit juice due to its known effect on drug metabolism.

Q: Can Paracide affect fertility or pregnancy planning?

Regulatory information addresses reproductive safety, noting that animal studies have found no evidence of harm to fertility. However, the information also notes that human data regarding use in pregnancy is limited or non-conclusive.

Q: Can Paracide cause problems with my stomach or digestion?

Official documents list gastrointestinal issues such as nausea and vomiting among the common adverse reactions. Less frequently, reactions like abdominal pain may also be documented. These effects relate to the drug's impact on the digestive system.

Q: Is it normal to feel no immediate difference after starting Paracide?

Patient information indicates that pain or fever relief is not instantaneous. The expected onset of effect is gradual, typically beginning within 30 to 60 minutes after taking the dose. A lack of immediate sensation of relief is consistent with the drug's expected onset profile.

Q: Why are there warnings about pre-existing conditions and Paracide?

Warnings are issued because the drug is primarily metabolized by the liver. Existing conditions, such as severe hepatic impairment, can lead to drug accumulation, which increases the risk of serious adverse reactions, including liver failure.

Q: Why do official documents mention specific populations that should avoid Paracide?

Contraindications are established for populations where known risks of the drug are likely to outweigh any potential therapeutic benefit. This primarily applies to populations with severe organ impairment (e.g., liver issues) where altered drug metabolism could lead to increased systemic exposure and risk.

Q: How is the dose of Paracide typically determined by doctors?

Dosing is determined by the patient’s age, their body weight (in pediatric cases), and the severity of the condition being treated. Regulatory documents provide the maximum recommended daily dosage and required time interval that prescribers follow.

Q: Is Paracide safe to use for people over 65?

Official safety data does not generally show a difference in efficacy or safety between the elderly (over 65) and younger adults. However, use in this population is often approached with caution due to the greater likelihood of decreased renal function in older adults.

Q: Are there certain times of day that Paracide is usually taken?

The regulatory documents do not specify a time of day (morning or night) for taking the drug. They mandate that the drug is taken as needed with a minimum interval of 4 to 6 hours between doses, leaving the exact timing flexible based on the patient's need.

Q: Why might Paracide not work for some people?

Regulatory documents describe variability in how individuals metabolize the drug. This suggests that certain genetic differences can affect the body’s ability to convert the drug into its active form, potentially leading to reduced efficacy in some patients.

Q: Do men and women experience Paracide side effects differently?

The official summary of clinical trials does not report any clinically meaningful differences in the adverse reaction profile or efficacy between male and female patients. Safety and effectiveness data are generally consistent across genders.

Q: How does Paracide's function relate to the body's immune system?

The drug’s regulatory mechanism of action section describes the primary effect as the central inhibition of pain and fever signals. There are no direct claims regarding modulation or direct action on the systemic immune response.

How should Paracide be stored and disposed of?

How to Store and Dispose of Paracide?

Official regulatory guidelines mandate specific conditions for storing and disposing of Paracide (Acetabromide) to maintain its quality and prevent harm.


Storage Requirements

Paracide must be stored at controlled room temperature, generally defined as 20 C to 25 C. The product must be protected from both excessive heat and moisture.

It is mandatory to store the medicine in its original container, which must be kept tightly closed. Liquid forms should not be frozen. Crucially, Paracide must be kept securely out of the sight and reach of children.

Disposal Instructions

Unused or expired Paracide should be discarded via an authorized medicine take-back program or disposed of according to local authority rules for medicinal waste. It is prohibited to dispose of the medication by pouring it down a sink or flushing it down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracide found in:

A-Z Index: